NEURO61

Session information

[held on paper]Oral Session

[O-21] Oral Session 21
Cerebrovascular disease (clinical research 3) E

Munehisa Shimamura1,2, Koichi Kaikita3, Tsutomu Sasaki1, Tomohiro Kawano1, Kenichi Tsujita3, Hideki Mochizuki1 (1.Department of Neurology, Osaka University Graduate School of Medicine, Japan, 2.Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Japan, 3.Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University)

Junlei Chang1, Song Ta2, Zhen-ni Guo2, Hang Jin2, Peng Zhang2, Fenge Li2, Chenqing Zeng3, Qingquan Gu3, Yuan Zhang4, Wenlan Liu4, Yi Yang2, Xian-fang Rong1 (1.Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China, 2.Dept of Neurology, The First Hospital of Jilin University, 3.Shenzhen RealOmics Biotech Co., Ltd., 4.Shenzhen Second People's Hospital)

Koji Tanaka1, Shoji Matsumoto2, Gulibahaer Ainiding1, Ichiro Nakahara2, Akira Ishii3, Taketo Hatano3, Kyoko Iinuma1, Takuya Matsushita1, Noriko Isobe4, Ryo Yamasaki3, Izumi Nagata1, Jun-ichi Kira1 (1.Department of Neurology, Neurological Institutes, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Department of Comprehensive Strokology, Fujita Health University School of Medicine, 3.Department of Neurology, Kokura Memorial Hospital, 4.Department of Neurological Therapeutics, Graduate School of Medical Sciences, Kyushu University)

Sho Nakajima1, Ryota Tanaka1,2, Kazuo Yamashiro1, Asako Chiba3, Daisuke Noto3, Hideki Shimura4, Naohide Kurita4, Kenichiro Hira1, Nobukazu Miyamoto1, Yuji Ueno1, Takao Urabe4, Sachiko Miyake3, Nobutaka Hattori1 (1.Department of Neurology, Juntendo University School of Medicine, Japan, 2.Stroke Center, Jichi Medical University Hospital, Division of Neurology, Department of Medicine, Jichi Medical University, 3.Department of Immunology, Juntendo University School of Medicine, 4.Department of Neurology, Juntendo University Urayasu Hospital)